Health News

Wyeth Pharmaceuticals, a division of Wyeth, and Santaris Pharma have announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris Pharma’s proprietary Locked Nucleic Acid (LNA) drug platform, which allows specific targeting and regulation of microRNAs (miRNAs) and messenger RNAs (mRNAs) as a means to affect gene expression mediated by the targeted RNAs.

Read more

Filed under: Pharmacy News
Tags: Drug, gene, medicine, Pharmacy

Related posts

• Rare Gene Variants Critical For Personalized Drug Treatment Discovered By Pharmacogenomics Study (0)
  The use of genetic tests to predict a patient's response to drugs is increasingly important in the development of personalized medicine. But genetic tests often only look for the most common gene variants... Read more [tags] Pharmacy News [/tags]
  
  
• Possible drug target for obesity treatment a no-brainer: UNC study (0)
  Scientists at the University of North Carolina at Chapel Hill School of Medicine have discovered a gene that when mutated causes obesity by dampening the body's ability to burn energy while leaving appetite unaffected. Read more [tags] Pharmacy News [/tags]
  
  
• Identifying Drugs That Could Help Fight Broad Range Of Viruses (0)
  Results of a new study demonstrate the feasibility of a novel strategy in drug discovery: screening large numbers of existing drugs - often already approved for other uses - to see which ones activate genes that boost natural immunity. Using an automated, high-volume screening technique, researchers at Washington University School of Medicine in St... Read more [tags] [...]
  
  
• How drug companies covertly promote off-label drug use (0)
  Off-label prescription of a drug is generally legal, but promotion of off-label uses by a drug manufacturer is illegal. In an article in this week's PLoS Medicine, two physician researchers describe the techniques that drug companies use to covertly promote off-label use, even when such promotion is illegal. Read more [tags]Pharmacy News[/tags]
  
  
• Genotoxic impurities in prescription drugs (0)
  Drug manufacturers have been adjusting to strict new government standards that limit the amount of potentially harmful impurities in medicine, according to the cover story of the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine. The impurities are "genotoxic," capable of damaging the DNA in genes. Read more [tags] Pharmacy News [/tags]